- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 6 x LQJ: 3'-O-[(R)-{[(2S,3aS,4S,6S,6aS)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxotetrahydro-2H-2lambda~5~-furo[3,4-d][1,3,2]dioxaphosphol-4-yl]methoxy}(hydroxy)phosphoryl]adenosine(Non-covalent)(Covalent)
LQJ.2: 19 residues within 4Å:- Chain A: G.12, T.13, A.14, T.37, Q.67, G.102, G.103, F.104, K.105
- Chain B: I.17, E.20, T.101, K.105, V.126, L.127, A.128, M.140, P.141
- Ligands: LQJ.4
11 PLIP interactions:9 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:T.13, A:A.14, A:T.37, A:G.103, A:F.104, A:K.105, A:K.105, B:P.141
- pi-Stacking: A:F.104, A:F.104
- Salt bridges: B:K.105
LQJ.4: 19 residues within 4Å:- Chain A: I.17, E.20, T.101, H.125, V.126, L.127, A.128, M.140, P.141
- Chain B: G.12, T.13, A.14, T.37, Q.67, G.102, G.103, F.104, K.105
- Ligands: LQJ.2
12 PLIP interactions:3 interactions with chain A, 9 interactions with chain B- Hydrogen bonds: A:P.141, B:T.13, B:A.14, B:T.37, B:T.37, B:G.103, B:K.105, B:K.105
- Salt bridges: A:K.105, A:H.125
- pi-Stacking: B:F.104, B:F.104
LQJ.6: 20 residues within 4Å:- Chain C: G.12, T.13, A.14, T.37, R.39, Q.67, G.102, G.103, F.104, K.105
- Chain D: I.17, E.20, T.101, H.125, V.126, L.127, A.128, M.140, P.141
- Ligands: LQJ.8
11 PLIP interactions:9 interactions with chain C, 2 interactions with chain D- Hydrogen bonds: C:T.13, C:A.14, C:T.37, C:T.37, C:G.103, C:F.104, C:K.105, C:K.105, D:P.141
- pi-Stacking: C:F.104
- Salt bridges: D:H.125
LQJ.8: 19 residues within 4Å:- Chain C: E.20, T.101, K.105, H.125, V.126, L.127, A.128, M.140, P.141
- Chain D: G.12, T.13, A.14, T.37, Q.67, G.102, G.103, F.104, K.105
- Ligands: LQJ.6
11 PLIP interactions:8 interactions with chain D, 3 interactions with chain C- Hydrogen bonds: D:T.13, D:A.14, D:T.37, D:G.103, D:K.105, D:K.105, C:P.141
- pi-Stacking: D:F.104, D:F.104
- Salt bridges: C:K.105, C:H.125
LQJ.11: 20 residues within 4Å:- Chain E: I.17, E.20, T.101, K.105, H.125, V.126, L.127, A.128, M.140, P.141
- Chain F: G.12, T.13, A.14, T.37, Q.67, G.102, G.103, F.104, K.105
- Ligands: LQJ.12
12 PLIP interactions:3 interactions with chain E, 9 interactions with chain F- Hydrogen bonds: E:P.141, F:T.13, F:T.37, F:T.37, F:G.103, F:K.105, F:K.105
- Salt bridges: E:K.105, E:H.125, F:K.105
- pi-Stacking: F:F.104, F:F.104
LQJ.12: 20 residues within 4Å:- Chain E: G.12, T.13, A.14, T.37, R.39, Q.67, G.102, G.103, F.104, K.105
- Chain F: I.17, E.20, T.101, K.105, V.126, L.127, A.128, M.140, P.141
- Ligands: LQJ.11
7 PLIP interactions:5 interactions with chain E, 2 interactions with chain F- Hydrogen bonds: E:T.13, E:T.37, E:G.103, E:K.105, F:P.141
- pi-Stacking: E:F.104
- Salt bridges: F:K.105
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Antiviral signaling of a type III CRISPR-associated deaminase. Science (2025)
- Release Date
- 2024-12-25
- Peptides
- Adenosine deaminase domain-containing protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 6 x LQJ: 3'-O-[(R)-{[(2S,3aS,4S,6S,6aS)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxotetrahydro-2H-2lambda~5~-furo[3,4-d][1,3,2]dioxaphosphol-4-yl]methoxy}(hydroxy)phosphoryl]adenosine(Non-covalent)(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, Y. et al., Antiviral signaling of a type III CRISPR-associated deaminase. Science (2025)
- Release Date
- 2024-12-25
- Peptides
- Adenosine deaminase domain-containing protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F